| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...883577A |
| P356 | DOI | 10.1371/JOURNAL.PONE.0083577 |
| P932 | PMC publication ID | 3858352 |
| P698 | PubMed publication ID | 24340102 |
| P5875 | ResearchGate publication ID | 259337541 |
| P2093 | author name string | Takao Tsuji | |
| Hideyuki Arimitsu | |||
| Keiko Sasaki | |||
| Hiroe Kojima | |||
| Tadashi Yanaka | |||
| P2860 | cites work | Clinical application of Clostridium botulinum type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity | Q40095430 |
| Purification and characterization of an Escherichia coli Shiga-like toxin II variant | Q40154038 | ||
| Quantitative microtiter cytotoxicity assay for Shigella toxin. | Q40230921 | ||
| Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli | Q42653384 | ||
| Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease | Q43654014 | ||
| Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli | Q45357221 | ||
| Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production. | Q54323381 | ||
| Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. | Q54644600 | ||
| Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. | Q54645159 | ||
| Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant | Q54703471 | ||
| Thiophilic adsorption of immunoglobulins--analysis of conditions optimal for selective immobilization and purification | Q68932921 | ||
| Globotetraosylceramide is recognized by the pig edema disease toxin | Q69517260 | ||
| Thiophilic adsorption--a new method for protein fractionation | Q70109252 | ||
| Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography | Q73933165 | ||
| Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome | Q33365488 | ||
| Edema disease | Q33856899 | ||
| Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. | Q35396919 | ||
| Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine | Q35461166 | ||
| Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid | Q35665444 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| The pathogenesis of edema disease in pigs. A review | Q36303500 | ||
| Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | Q36785336 | ||
| An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine | Q36957798 | ||
| Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 | Q36974749 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. | Q38323078 | ||
| Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography | Q38342831 | ||
| Purification of Shiga-like toxin 1 by pigeon egg white glycoproteins immobilized on Sepharose gels | Q38360747 | ||
| A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. | Q39485510 | ||
| Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates | Q39556186 | ||
| Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia | Q39730246 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | affinity chromatography | Q382799 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e83577 | |
| P577 | publication date | 2013-12-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group | |
| P478 | volume | 8 |
| Q88298494 | Affinity chromatography for vaccines manufacturing: Finally ready for prime time? |
| Q53144080 | Development of a simple and rapid diagnosis method for swine edema disease to specifically detect Stx2e protein by immunochromatographic test. |
| Q38927469 | Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2. |
Search more.